[HTML][HTML] Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR
NL Bayless, JA Bluestone, S Bucktrout… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Recent advances in cancer immunotherapy have completely revolutionized cancer
treatment strategies. Nonetheless, the increasing incidence of immune-related adverse …
treatment strategies. Nonetheless, the increasing incidence of immune-related adverse …